Skip to main content

Table 3 Phases II trials evaluating taxanes based doublets

From: Chemotherapy in advanced bladder cancer: current status and future

Authors

Treatments

N

Results

Burch et al [21]

PC

34

ORR = 70%

Dreicer et al [22]

PC

52

ORR = 50%

OS = 10.6 months

Dimopoulos et al [23]

DC

66

ORR = 52%

TTP = 5 months

OS = 8 months

DelMuro et al [24]

DC

38

ORR = 58%

TTP = 6.9 months

OS = 10.4 months.

Sengelov et al [25]

DC

25

ORR = 60%

OS = 13.6 months

  1. Abbreviations. PC: paclitaxel-cisplatin; DC: docetaxel-cisplatin; ORR: overall response rate; OS: overall survival; TTP: time to progression.